The Johnson & Johnson (J&J) COVID-19 vaccine will remain on pause after an advisory committee to the Centers for Disease Control and Prevention (CDC) said it needed more data to be able to vote on a recommendation, which may come in a week to 10 days.
Federal health officials halted the use of the J&J vaccine after reports of rare and severe blood clots in the brain with reduced blood platelet levels (thrombocytopenia) occurred after some people were inoculated.
